YKL-40, a glycoprotein expressed by astrocytes [70], is elevated in the brain and CSF of AD patients [20, 48] and is a potential diagnostic biomarker for neurodegenerative diseases [2, 15]. The gene discussed is CHI3L1; the disease is Alzheimer disease.